Boston Scientific Acquires Tumor Surgery Technology

New England Council member Boston Scientific recently acquired a medical device that improves endoscopic surgery for precancerous tumors.

Boston Scientific purchased the LumenR Tissue Retractor System from LumenR LCC. The system can make endoscopic submucosal dissection and endoscopic mucosal resection easier and faster, leading to better care for patients. It improves visualizations of lesions, making it easier for surgeons to complete the procedures.

“We are excited about the potential of the LumenR system to improve visibility and control during ESD and EMR procedures and improve quality of life for patients,” said Art Butcher, senior vice president and president, endoscopy. “Every year, patients around the world undergo open gastrointestinal surgery that has a profound impact on their lives. By bringing this innovative technology forward, we have an opportunity for more physicians to treat patients successfully through less invasive endoscopic procedures.”

The New England Council congratulates Boston Scientific on the acquisition and for continuing to innovate in healthcare. Read more in the press release and the Worcester Business Journal.

Recently from the Blog

Media Panel Discusses Biden’s First 100 Days

05/3/2021 | Read Post

Second “Investing in Infrastructure” Program to Focus on Energy

04/29/2021 | Read Post

In the News

NEC Board Elects Three New Directors

04/27/2021 | Read Press Release

NEC Endorses Cannabis Banking Legislation

04/1/2021 | Read Press Release